Home - Products - Autophagy - CXCR - USL311

USL311

CAS No. 1373268-67-7

USL311( —— )

Catalog No. M22471 CAS No. 1373268-67-7

USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4. USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	85	In Stock
5MG	77	In Stock
10MG	123	In Stock
25MG	250	In Stock
50MG	384	In Stock
100MG	616	In Stock
200MG	Get Quote	In Stock
500MG	1277	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

USL311
Note

Research use only, not for human use.
Brief Description

USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4. USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.
Description

USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4. USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Autophagy
Target

CXCR
Recptor

CXCR4
Research Area

Cancer
Indication

Solid Tumors (Phase 1)Relapsed/Recurrent GBM (Phase 2)

Chemical Information

CAS Number

1373268-67-7
Formula Weight

422.57
Molecular Formula

C24H34N6O
Purity

>98% (HPLC)
Solubility

DMSO:24 mg/mL (59.79 mM; Need ultrasonic)
SMILES

CC(C)N1CCC(CC1)N1CCCN(CC1)c1cccc(n1)C(=O)Nc1ccncc1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Peter Richardson. Usl-311 for use in the treatment of cancer. WO2018162924A1

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Eldelumab

Eldelumab (BMS-936557) is a humanized anti-IP-10 IgG type 1 monoclonal antibody with inhibitory activity against CXCL10. It has anti-inflammatory properties, selectively binds to CXCL10, and can be used in the study of rheumatoid arthritis, ulcerative colitis, and Crohn's disease.
CHIR98014

CHIR 98014 is a potent GSK-3α/β inhibitor with IC50 of 0.65 nM/0.58 nM in cell-free assays, with the ability to distinguish GSK-3 from its closest homologs Cdc2 and ERK2.
Cefoselis Sulfate

Cefoselis is a widely used beta-lactam antibiotic.

Sign In Join Free